Key terms
About ORGO
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ORGO news
Apr 03
7:38am ET
Organogenesis announces favorable court ruling dismissing securities fraud case
Mar 19
6:19am ET
Buy Rating Affirmed for Organogenesis Holdings Amid Stable Product Pricing and Positive Market Dynamics
Mar 01
6:58am ET
Organogenesis Holdings: A Buy Rating with Anticipated Turnaround and Growth Prospects
Feb 29
4:27pm ET
Organogenesis reports Q4 EPS 0c, consensus 1c
Feb 07
6:11am ET
Organogenesis initiated with an Overweight at Cantor Fitzgerald
Jan 07
5:41am ET
BTIG Sticks to Its Buy Rating for Organogenesis Holdings (ORGO)
No recent press releases are available for ORGO
ORGO Financials
Key terms
Ad Feedback
ORGO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ORGO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
